18.  BUSINESS SEGMENT

The Company operates in a single reportable segment, referred to as safety medical syringes and other safety medical devices. The business is managed by the chief executive officer who is the Chief Operating Decision Maker (CODM). The CODM evaluates segment performance based on operating income (loss) for purposes of allocating resources and evaluating financial performance.  The accounting policies of the Company’s single reportable segment are the same as those for the Company as a whole.

The following are summaries of the Company’s sales and long-lived assets by geography:

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

U.S. sales

$

32,236,899

$

29,374,145

$

34,599,754

North and South America sales (excluding U.S.)

 

5,060,698

 

1,960,769

 

6,085,166

Other international sales

 

968,614

 

1,714,619

 

2,912,006

Total sales

$

38,266,211

$

33,049,533

$

43,596,926

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

Long-lived assets

U.S.

$

75,996,168

$

83,373,876

International

3,183,881

3,974,642

Total

$

79,180,049

$

87,348,518

Shipments to international customers generally require a prepayment either by wire transfer or an irrevocable confirmed letter of credit.  The Company does extend credit to international customers on some occasions depending upon certain criteria, including, but not limited to, the credit worthiness of the customer, the stability of the country, banking restrictions, and the size of the order.  All transactions are in U.S. currency.

Historical Timeline

Fiscal YearFiled
2025Mar 27, 2026Showing above
2024Mar 28, 2025
2023Mar 29, 2024
2022Mar 30, 2023
2021Mar 31, 2022
2020Mar 31, 2021
2019Mar 30, 2020
2018Mar 28, 2019
2017Apr 2, 2018
2016Mar 31, 2017
2015Mar 30, 2016

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.